Peripheral Neuropathy Designated Among Conditions Eligible for Research!
On November 10, 2020, the Senate Committee on Appropriations released their version of the fiscal year 2021 Defense Appropriations Act. We are excited to report that this legislation includes “peripheral neuropathy” among the conditions eligible for research under the Peer-Reviewed Medical Research Program (PRMRP).
This accomplishment would not have been possible without the efforts of individuals like you who contacted their members of Congress earlier this year to encourage them to support this request. Thanks to you, we have overcome a significant hurdle; but we’re not across the finish line yet.
Please take the time over the next two weeks to contact your senators and encourage them to approve the Senate version of the FY21 Defense Appropriations Act, and work to ensure that the “peripheral neuropathy” designation is included in the PRMRP in the final enacted version of the Defense Appropriations Act.
Ask the Expert: Popular Questions from PN Patients
Following a recent webinar on current research trends, FPN’s Executive Director caught up with the program’s panelists to follow-up on some important questions that the program didn’t have time to cover.
Interested in watching the recording of the October 20, 2020 program? Go to the FPN Media Center and log in with your Premium Membership account, as this program was an exclusive series to FPN’s top donors and Premium Members. Thank you to our generous supporters for making these programs possible!
Donations up to $300 per person are eligible for tax deductions, even if the donor does not itemize in their 2020 tax returns. We are always grateful for the generosity of our donors, and even more so when they are able to benefit as well!